Skip to main content

TERAZOSIN HYDROCHLORIDE

NDC 24689-003 · Apnar Pharma LP

Generic nameterazosin hydrochloride
Dosage formCAPSULE
RouteORAL
Active ingredient(s)TERAZOSIN HYDROCHLORIDE
Strength5 mg/1
Pharmacologic classAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
Marketing categoryANDA

Packages

24689-003-01 — 100 CAPSULE in 1 BOTTLE (24689-003-01)

24689-003-10 — 1000 CAPSULE in 1 BOTTLE (24689-003-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

23155-735 — terazosin, 23155-736 — terazosin, 23155-737 — terazosin, 23155-738 — terazosin, 24689-001 — terazosin hydrochloride, 24689-002 — terazosin hydrochloride, 24689-004 — terazosin hydrochloride, 27241-288 — Terazosin, 27241-289 — Terazosin, 27241-290 — Terazosin, 27241-291 — Terazosin, 42291-820 — Terazosin Hydrochloride, 42291-821 — Terazosin Hydrochloride, 42291-822 — Terazosin Hydrochloride, 42291-823 — Terazosin Hydrochloride, 50090-0657 — Terazosin Hydrochloride, 50090-2371 — Terazosin Hydrochloride, 50090-2623 — Terazosin Hydrochloride, 50090-7851 — terazosin, 50268-764 — Terazosin Hydrochloride, +62 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels